89 related articles for article (PubMed ID: 20540035)
21. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit.
de la Cal MA; Cerdá E; van Saene HK; García-Hierro P; Negro E; Parra ML; Arias S; Ballesteros D
J Hosp Infect; 2004 Mar; 56(3):175-83. PubMed ID: 15003664
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin therapy for treatment of peritonitis in outpatients on peritoneal dialysis.
Yorioka N; Taniguchi Y; Ito T; Katsutani M; Amimoto D; Masaki T; Nishida Y; Kushihata S; Oda H; Yamakido M
Hiroshima J Med Sci; 1998 Sep; 47(3):105-7. PubMed ID: 9810781
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin Dosing Regimen by Monte Carlo Simulation in Patients on Intermittent High-Efficiency Hemodialysis (HEHD).
Rungprai D; Jaruratanasirikul S; Wongpoowarak W; Pattharachayakul S; Wanakamanee U; Dandecha P; Jitsurong A
J Med Assoc Thai; 2015 Jun; 98(6):606-15. PubMed ID: 26219166
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis.
Crew P; Heintz SJ; Heintz BH
Am J Health Syst Pharm; 2015 Nov; 72(21):1856-64. PubMed ID: 26490819
[TBL] [Abstract][Full Text] [Related]
26. Concentrations of vancomycin in human bone.
Borner K; Hahn F; Koeppe P
J Chemother; 1989 Jul; 1(4 Suppl):588-9. PubMed ID: 16312546
[No Abstract] [Full Text] [Related]
27. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
[TBL] [Abstract][Full Text] [Related]
28. Once-weekly vancomycin for patients receiving high-flux hemodialysis.
Crawford BS; Largen RF; Walton T; Doran JJ
Am J Health Syst Pharm; 2008 Jul; 65(13):1248-53. PubMed ID: 18574015
[TBL] [Abstract][Full Text] [Related]
29. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
[TBL] [Abstract][Full Text] [Related]
30. Failure of once-daily vancomycin for staphylococcal endocarditis.
Marik PE
Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
[TBL] [Abstract][Full Text] [Related]
31. An improved method of vancomycin administration to dialysis patients.
Edell LS; Westby GR; Gould SR
Clin Nephrol; 1988 Feb; 29(2):86-7. PubMed ID: 3359698
[TBL] [Abstract][Full Text] [Related]
32. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
Teigen MM; Duffull S; Dang L; Johnson DW
J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
[TBL] [Abstract][Full Text] [Related]
33. Effects of dialysis membrane on intradialytic vancomycin administration.
Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
Toussaint N; Mullins K; Snider J; Murphy B; Langham R; Gock H
Nephrology (Carlton); 2005 Apr; 10(2):142-6. PubMed ID: 15877673
[TBL] [Abstract][Full Text] [Related]
35. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of combination use of antibiotic-loaded PerOssal with spinal surgery in patients with spondylodiscitis.
von Stechow D; Rauschmann MA
Eur Surg Res; 2009; 43(3):298-305. PubMed ID: 19684405
[TBL] [Abstract][Full Text] [Related]
37. Administration of tobramycin in the beginning of the hemodialysis session: a novel intradialytic dosing regimen.
Kamel Mohamed OH; Wahba IM; Watnick S; Earle SB; Bennett WM; Ayres JW; Munar MY
Clin J Am Soc Nephrol; 2007 Jul; 2(4):694-9. PubMed ID: 17699484
[TBL] [Abstract][Full Text] [Related]
38. Vancomycin dosing in patients undergoing maintenance hemodialysis.
Rymarz A; Brodowska-Kania D; Gomółka M; Józefczak-Bergier E; Dzierżanowska M; Niemczyk S
Int Urol Nephrol; 2014 Aug; 46(8):1681-2. PubMed ID: 24696106
[No Abstract] [Full Text] [Related]
39. Vancomycin use in patients requiring hemodialysis: a literature review.
Pallotta KE; Manley HJ
Semin Dial; 2008; 21(1):63-70. PubMed ID: 18251960
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
